2021 research period for North America is officially open
March 24, 2021
Research team is now accepting firm submissions, due June 1
US
FDA: Medical Device
| FDA: Medical Devices — Highly Recommended |
|---|
| Hogan Lovells |
| Hyman Phelps & McNamara |
| King & Spalding |
| Ropes & Gray |
| FDA: Medical Devices — Recommended |
|---|
| Arnold & Porter |
| Covington & Burling |
| McDermott Will & Emery |
| Morgan Lewis & Bockius |
| Sidley Austin |
FDA: Pharmaceutical
| FDA: Pharmaceutical — Highly Recommended |
|---|
| Covington & Burling |
| Hogan Lovells |
| Hyman Phelps & McNamara |
| Sidley Austin |
| FDA: Pharmaceutical — Recommended |
|---|
| Arnold & Porter |
| King & Spalding |
| Morgan Lewis & Bockius |
| Ropes & Gray |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Dormer, Robert A | Regulatory | FDA: Pharmaceutical, FDA: Medical Device | Washington, D.C. |
| Gibbs, Jeffrey N | Regulatory | FDA: Pharmaceutical, FDA: Medical Device | Washington, D.C. |
| Gilbert, John | Regulatory | FDA: Pharmaceutical | Washington, D.C. |
| Javitt, Gail | Regulatory | FDA: Pharmaceutical, FDA: Medical Device | Washington, D.C. |
| Karst, Kurt | Regulatory | FDA: Pharmaceutical | Washington, D.C. |
| Kirschenbaum, Alan | Regulatory | FDA: Pharmaceutical, FDA: Medical Device, Healthcare Pricing & Reimbursement | Washington, D.C. |
| Sasinowski, Frank J | Regulatory | FDA: Pharmaceutical | Washington, D.C. |
| Shapiro, Jeffrey | Regulatory | FDA: Medical Device | Washington, D.C. |
| Torrente, Josephine | Regulatory | FDA: Pharmaceutical | Washington, D.C. |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Regulatory
Hyman Phelps & McNamara
Hyman Phelps & McNamara is a boutique law firm that solely focuses on regulatory matters. The firm assists a variety of pharmaceutical and medical device companies with their regulatory issues. As a boutique, Hyman Phelps provides clients with FDA expertise throughout all stages of product development, including pre-market approvals and compliance, to post-market labeling, advertising and promotion. One peer notes the firm is an “absolute juggernaut” in the space.
Jeffrey Gibbs offers his extensive experience handling FDA regulatory issues on behalf of clients in the life sciences industry. His active practice primarily involves counseling medical device companies. Gibbs assists with regulatory strategy, 510(k) clearances, approvals, and post-market regulation advice and guidance.
On the pharmaceutical side, Josephine Torrente assists companies at every stage of product development, from pretrial counseling to post-market representation in front of the FDA. Torrente advises clients on a variety of drug development issues, specifically focusing on serious and life-threating diseases.
Jeffrey Shapiro is highly regarded for his work representing clients in the medical device area. Shapiro has over 20 years of experience assisting clients before the FDA and is considered an expert in the regulation of combination products. "Jeff Shapiro and his team have done a fantastic job for us in many circumstances, including high-pressure situations with short deadlines," a medical device client says.